amobarbital has been researched along with Vision, Diminished in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| NATHANSON, M | 2 |
| BERGMAN, PS | 2 |
| BENDER, MB | 2 |
2 other studies available for amobarbital and Vision, Diminished
| Article | Year |
|---|---|
Visual disturbances as the result of nystagmus on direct forward gaze; effect of amobarbital (amytal) sodium.
Topics: Amobarbital; Barbiturates; Humans; Multiple Sclerosis; Nystagmus, Pathologic; Sodium; Vision, Low; V | 1953 |
Visual disturbances as the result of nystagmus on direct forward gaze; effect of sodium amytal.
Topics: Amobarbital; Barbiturates; Humans; Nystagmus, Pathologic; Vision, Low; Vision, Ocular | 1952 |